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Each October, two or three
researchers in biology get the best
possible news — they’ve just won
a Nobel Prize. Two or three
hundred other researchers in
biology figure, maybe next year.
But this year, the story didn’t quite
unfold that way. 
Dr. Raymond Damadian was so
fixated on the Nobel Prize, he told
the Washington Post he got up at
5:30 in the morning to check the
Nobel web site to see if he’d won.
When two other people in his field
did — but he did not — he was
furious. It’s by no means the first
time someone felt snubbed by the
Nobel Committee. But Damadian
was having none of it. He plunked
down what the Los Angeles Times
figured was $290,000 to buy full
page ads in the L.A. Times, New
York Times and Washington Post,
to declare that a fraud had been
perpetrated upon him. 
He holds a key patent for
Magnetic Resonance Imaging,
along with the National Medal of
Technology. But Nobel’s gold
eluded him. “Damadian has
frequently said, ‘Had I never been
born, there would be no MRI
today,’ and he said it again to
reporters Friday. ‘I can’t escape
the fact that I started it all.’”, the
L.A. Times reported. His ad
featured an upside down Nobel
medal, with the headline, “The
Shameful Wrong That Must Be
Righted.” 
Damadian’s company bought
the ads. And it could well afford to
do so. Damadian told several
reporters that his company had
won a $129 million patent suit
against General Electric for MRI
technology. The inventor and
medical doctor tried to start a
letter-writing campaign to the
Nobel committee, to overturn its
decision. That strategy had
essentially no chance of success
— the committee must have
known all about Damadian and
decided not to include him in the
award.
“This is the first time I have
heard of somebody taking out an
advertisement,” Nobel Assembly
secretary Hans Jornvall said, in a
quote that made a Reuters
dispatch as well as the
Independent. “Science is my life. I
would like it always to be happy
but this situation is clearly not
happy.” The winners — Paul
Lauterbur and Sir Peter Mansfield
— declined to comment on the
controversy. They are credited not
with the idea of MRI, but with
advances that made it possible to
produce images of the human
body. Damadian may have
developed the idea for MRI and a
crude machine, but he didn’t
succeed in making images. A
letter in the Washington Post
noted “not even the company he
founded uses his method.” 
That letter was in response to a
largely sympathetic article in the
newspaper’s “Style” section.
“Damadian’s camp characterizes
Lauterbur’s and Mansfield’s work
as technological refinements of
Damadian’s central insight,” the
Post reported, “while the Nobel
Assembly and other scientists say
Lauterbur’s and Mansfield’s
breakthroughs were ‘discoveries’
in their own right.” 
The Wall Street Journal was not
nearly so generous. “Dr.
Damadian is an unceasing self-
promoter and — thanks to court
rulings favoring his company in a
patent dispute — a wealthy
businessman.” The Journal said
Damadian’s supporters wondered
“whether his penchant for legal
battles and the perception of him
as an abrasive egotist had
something to do with the Nobel
committee’s decision.” 
“Another trait that distinguishes
Dr. Damadian from most scientists
in the U.S. is his advocacy of
creationism,” the Journal
reported. “He says he has studied
the matter in depth and believes
‘evolution is false.’ Officially, of
course, the Nobel prizes are
supposed to be an evaluation of
scientific achievement, not a
personality contest.” 
An editorial in the L.A. Times
even weighed in on the subject.
“Like some mad comic book
scientist, [Damadian] tested his
first scanner, which he
immodestly dubbed ‘Indomitable,’
in 1977 by wiggling his own body
into its shiny corset-like antenna
coil. Then he wrote a boastful
press release about his ‘perfected’
technique for cancer detection.” 
Some of Damadian’s support
came from people anxious to
bask in the reflected glory. “The
reason that we are so
disappointed and even angry is
because the work was done here
at this institution, at this medical
school,” Dr. Eugene Feigelson,
dean of the State University of
New York College of Medicine
told Reuters. 
As the New York Times noted,
the dispute between Damadian
and Lauterbur “has been known
for years in academic circles, with
some fearing that the Nobel
committee would steer clear of
magnetic resonance imaging
altogether because of the
Swedes’ supposed distaste for
controversial discoveries. Dr.
Lauterbur, 74, is not in good
health, and the committee may
have decided that its prize, which
cannot be given posthumously,
needed to be awarded for the
discovery now or never.” 
Why the Nobel committee
honored Lauterbur and Mansfield
but not Damadian will come to
light: its notes on the subject will
be opened in 2053. 
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The secrecy surrounding the decisions about who should and who
should not receive a Nobel prize led one potential contender to go to the
press. Richard F. Harris reports.
